FDMT. – 4D Molecular Therapeutics Inc
4D Molecular Therapeutics, Inc.FDMT
$6.42Name : 4D Molecular Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $297,403,936.00
EPSttm : -3.18
4D Molecular Therapeutics, Inc.
$6.42
42.67%$1.92Float Short %
8.71
Margin Of Safety %
Put/Call OI Ratio
0.03
EPS Next Q Diff
-0.08
EPS Last/This Y
-0.58
EPS This/Next Y
-0.32
Price
6.42
Target Price
29.56
Analyst Recom
1.82
Performance Q
86.63
Relative Volume
69.49
Beta
2.82
Ticker: FDMT
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | FDMT | 4.24 | 0.11 | 0.01 | 4437 |
| 2025-07-07 | FDMT | 3.96 | 0.11 | 0.00 | 4504 |
| 2025-07-08 | FDMT | 4.22 | 0.11 | 0.00 | 4678 |
| 2025-07-09 | FDMT | 4.42 | 0.10 | 0.00 | 4718 |
| 2025-07-10 | FDMT | 4.36 | 0.11 | 0.00 | 4673 |
| 2025-07-11 | FDMT | 4.28 | 0.11 | 0.00 | 4619 |
| 2025-07-14 | FDMT | 4.38 | 0.11 | 0.00 | 4619 |
| 2025-07-15 | FDMT | 4.18 | 0.11 | 0.77 | 4633 |
| 2025-07-16 | FDMT | 4.25 | 0.11 | 0.77 | 4633 |
| 2025-07-17 | FDMT | 4.36 | 0.11 | 0.00 | 4644 |
| 2025-07-18 | FDMT | 4.22 | 0.11 | 0.00 | 4683 |
| 2025-07-21 | FDMT | 4.24 | 0.04 | 0.00 | 2212 |
| 2025-07-22 | FDMT | 4.5 | 0.04 | 0.00 | 2253 |
| 2025-07-23 | FDMT | 4.72 | 0.04 | 0.00 | 2291 |
| 2025-07-24 | FDMT | 4.6 | 0.04 | 0.00 | 2375 |
| 2025-07-25 | FDMT | 4.56 | 0.04 | 0.00 | 2365 |
| 2025-07-28 | FDMT | 4.64 | 0.04 | 0.00 | 2378 |
| 2025-07-29 | FDMT | 4.36 | 0.03 | 0.00 | 2424 |
| 2025-07-30 | FDMT | 4.41 | 0.03 | 0.02 | 2461 |
| 2025-07-31 | FDMT | 4.5 | 0.03 | 0.00 | 2684 |
| 2025-08-01 | FDMT | 6.4 | 0.03 | 0.11 | 2766 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | FDMT | 4.24 | -9.9 | - | -3.56 |
| 2025-07-07 | FDMT | 3.95 | -9.9 | - | -3.56 |
| 2025-07-08 | FDMT | 4.22 | -9.9 | - | -3.56 |
| 2025-07-09 | FDMT | 4.42 | -9.9 | - | -3.56 |
| 2025-07-10 | FDMT | 4.35 | -9.9 | - | -3.56 |
| 2025-07-11 | FDMT | 4.28 | -9.9 | - | -3.56 |
| 2025-07-14 | FDMT | 4.38 | -9.9 | - | -3.56 |
| 2025-07-15 | FDMT | 4.16 | -9.9 | - | -3.56 |
| 2025-07-16 | FDMT | 4.25 | -9.9 | - | -3.56 |
| 2025-07-17 | FDMT | 4.36 | -9.9 | - | -3.56 |
| 2025-07-18 | FDMT | 4.22 | -9.9 | - | -3.56 |
| 2025-07-21 | FDMT | 4.22 | -9.9 | - | -3.56 |
| 2025-07-22 | FDMT | 4.50 | -9.9 | - | -3.56 |
| 2025-07-23 | FDMT | 4.71 | -9.9 | - | -3.56 |
| 2025-07-24 | FDMT | 4.61 | -9.9 | - | -3.56 |
| 2025-07-25 | FDMT | 4.57 | -9.9 | - | -3.56 |
| 2025-07-28 | FDMT | 4.64 | -9.9 | - | -3.56 |
| 2025-07-29 | FDMT | 4.36 | -9.9 | - | -3.56 |
| 2025-07-30 | FDMT | 4.41 | -9.9 | - | -3.56 |
| 2025-07-31 | FDMT | 4.50 | -9.9 | - | -3.56 |
| 2025-08-01 | FDMT | 6.42 | -9.9 | - | -3.56 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | FDMT | 0.00 | -8.49 | 10.04 |
| 2025-07-07 | FDMT | 0.00 | -8.50 | 10.04 |
| 2025-07-08 | FDMT | 0.00 | -8.50 | 10.04 |
| 2025-07-09 | FDMT | 0.00 | -8.50 | 10.04 |
| 2025-07-10 | FDMT | 0.00 | -8.50 | 10.04 |
| 2025-07-11 | FDMT | 0.00 | -8.50 | 9.35 |
| 2025-07-14 | FDMT | 0.00 | -16.30 | 9.35 |
| 2025-07-15 | FDMT | 0.00 | -16.30 | 9.35 |
| 2025-07-16 | FDMT | 0.00 | -16.30 | 9.35 |
| 2025-07-17 | FDMT | 0.00 | -16.30 | 9.35 |
| 2025-07-18 | FDMT | 0.00 | -16.30 | 9.35 |
| 2025-07-21 | FDMT | 0.00 | -8.39 | 9.35 |
| 2025-07-22 | FDMT | 0.00 | -8.39 | 9.35 |
| 2025-07-23 | FDMT | 0.00 | -8.39 | 9.35 |
| 2025-07-24 | FDMT | 0.00 | -8.39 | 9.35 |
| 2025-07-25 | FDMT | 0.00 | -8.39 | 8.71 |
| 2025-07-28 | FDMT | 0.00 | -8.09 | 8.71 |
| 2025-07-29 | FDMT | 0.00 | -8.09 | 8.71 |
| 2025-07-30 | FDMT | 0.00 | -8.09 | 8.71 |
| 2025-07-31 | FDMT | 0.00 | -8.09 | 8.71 |
| 2025-08-01 | FDMT | 0.00 | -8.09 | 8.71 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.86
Avg. EPS Est. Current Quarter
-0.69
Avg. EPS Est. Next Quarter
-0.94
Insider Transactions
Institutional Transactions
-8.09
Beta
2.82
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
19
Growth Score
28
Sentiment Score
5
Actual DrawDown %
88.4
Max Drawdown 5-Year %
Target Price
29.56
P/E
Forward P/E
PEG
P/S
14870.15
P/B
0.63
P/Free Cash Flow
EPS
-3.37
Average EPS Est. Cur. Y
-3.56
EPS Next Y. (Est.)
-3.88
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-767126.09
Relative Volume
69.49
Return on Equity vs Sector %
-61.3
Return on Equity vs Industry %
-42.7
EPS 1 7Days Diff
EPS 1 30Days Diff
0.01
EBIT Estimation
4D Molecular Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 227
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. The company is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in in preclinical stage for treating geographic atrophy; 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease; and 4D-310 that is in Phase 1 clinical trial for treating Fabry disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; and uniQure biopharma B.V. The company was founded in 2013 and is headquartered in Emeryville, California.
stock quote shares FDMT. – 4D Molecular Therapeutics Inc Stock Price stock today
news today FDMT. – 4D Molecular Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FDMT. – 4D Molecular Therapeutics Inc yahoo finance google finance
stock history FDMT. – 4D Molecular Therapeutics Inc invest stock market
stock prices FDMT premarket after hours
ticker FDMT fair value insiders trading